Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...
ELK GROVE VILLAGE, Ill., April 1, 2025 /PRNewswire/ -- Orsini, a leader in rare disease pharmacy solutions, has been selected by Neurotech Pharmaceuticals, Inc., as the exclusive specialty pharmacy ...
Please provide your email address to receive an email when new articles are posted on . Ahead of the encapsulated cell therapy’s June launch following its FDA approval earlier this year, the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback